SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001140361-23-018330
Filing Date
2023-04-14
Accepted
2023-04-14 06:03:34
Documents
9
Period of Report
2023-06-09

Document Format Files

Seq Description Document Type Size
1 PRE 14A ny20007145x1_pre14a.htm PRE 14A 1487748
2 ny20007145x1_barchart01x1.jpg GRAPHIC 100862
3 ny20007145x1_barchart02x1.jpg GRAPHIC 137359
4 ny20007145x1_barchart03x1.jpg GRAPHIC 127458
5 ny20007145x1_pc01x2.jpg GRAPHIC 740320
6 ny20007145x1_pc02x2.jpg GRAPHIC 668714
7 ny20007145x1_piechart01x1.jpg GRAPHIC 91888
8 ny20007145x1_piechart02.jpg GRAPHIC 80638
9 ny20007145x1_piechart03.jpg GRAPHIC 56918
  Complete submission text file 0001140361-23-018330.txt   4247477
Mailing Address 100 CARDINAL WAY REDWOOD CITY CA 94063
Business Address 100 CARDINAL WAY REDWOOD CITY CA 94063 (650) 649-1004
Adverum Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36579 | Film No.: 23819613
SIC: 2836 Biological Products, (No Diagnostic Substances)